Gary M. Levin

1.2k total citations
33 papers, 794 citations indexed

About

Gary M. Levin is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, Gary M. Levin has authored 33 papers receiving a total of 794 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Psychiatry and Mental health, 9 papers in Pharmacology and 6 papers in Clinical Psychology. Recurrent topics in Gary M. Levin's work include Schizophrenia research and treatment (11 papers), Bipolar Disorder and Treatment (7 papers) and Attention Deficit Hyperactivity Disorder (6 papers). Gary M. Levin is often cited by papers focused on Schizophrenia research and treatment (11 papers), Bipolar Disorder and Treatment (7 papers) and Attention Deficit Hyperactivity Disorder (6 papers). Gary M. Levin collaborates with scholars based in United States and India. Gary M. Levin's co-authors include Jennifer Y. Tan, Jessica L. Gören, Enrico Cabib, Blair Bowers, C. Lindsay DeVane, John P. Kemph, Ronald L. Miller, Michael Mullan, Corbin Bachmeier and David Beaulieu‐Abdelahad and has published in prestigious journals such as Journal of Bacteriology, Journal of the American Academy of Child & Adolescent Psychiatry and Journal of Pharmaceutical Sciences.

In The Last Decade

Gary M. Levin

32 papers receiving 731 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gary M. Levin United States	15	399	154	153	124	119	33	794
Bruno Pfuhlmann Germany	21	501 1.3×	216 1.4×	229 1.5×	86 0.7×	122 1.0×	76	1.1k
Chanoch Miodownik Israel	20	402 1.0×	191 1.2×	134 0.9×	134 1.1×	135 1.1×	43	1.1k
Concetta D’Arrigo Italy	14	488 1.2×	164 1.1×	196 1.3×	83 0.7×	56 0.5×	15	843
A. Fiorentini Italy	14	432 1.1×	162 1.1×	150 1.0×	99 0.8×	66 0.6×	31	841
Judith C. Kando United States	15	741 1.9×	135 0.9×	264 1.7×	99 0.8×	68 0.6×	40	1.2k
P. J. Perry United States	12	526 1.3×	93 0.6×	216 1.4×	138 1.1×	101 0.8×	20	872
Thomas Shiovitz United States	16	554 1.4×	179 1.2×	303 2.0×	106 0.9×	139 1.2×	28	1.2k
Mei‐Chun Hsiao Taiwan	18	203 0.5×	148 1.0×	129 0.8×	94 0.8×	84 0.7×	37	766
Stefan Unterecker Germany	14	372 0.9×	101 0.7×	235 1.5×	64 0.5×	64 0.5×	71	818
Heidi J. Wehring United States	21	484 1.2×	121 0.8×	105 0.7×	94 0.8×	126 1.1×	49	1.2k

Countries citing papers authored by Gary M. Levin

Since Specialization

Citations

This map shows the geographic impact of Gary M. Levin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary M. Levin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary M. Levin more than expected).

Fields of papers citing papers by Gary M. Levin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary M. Levin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary M. Levin. The network helps show where Gary M. Levin may publish in the future.

Co-authorship network of co-authors of Gary M. Levin

This figure shows the co-authorship network connecting the top 25 collaborators of Gary M. Levin. A scholar is included among the top collaborators of Gary M. Levin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary M. Levin. Gary M. Levin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bachmeier, Corbin, Gary M. Levin, David Beaulieu‐Abdelahad, Jon Reed, & Michael Mullan. (2013). Effect of Venlafaxine and Desvenlafaxine on Drug Efflux Protein Expression and Biodistribution In Vivo. Journal of Pharmaceutical Sciences. 102(10). 3838–3843. 20 indexed citations

Bachmeier, Corbin, et al.. (2011). Induction of drug efflux protein expression by venlafaxine but not desvenlafaxine. Biopharmaceutics & Drug Disposition. 32(4). 233–244. 40 indexed citations

Levin, Gary M., Megan J. Ehret, Taimour Langaee, et al.. (2007). Assessment of Human Serotonin 1A Receptor Polymorphisms and SSRI Responsiveness. Molecular Diagnosis & Therapy. 11(3). 155–160. 36 indexed citations

Ehret, Megan J. & Gary M. Levin. (2006). Long‐term Use of Atypical Antipsychotics in Bipolar Disorder. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(8). 1134–1147. 13 indexed citations

Gören, Jessica L. & Gary M. Levin. (2002). Discharge and Readmission Rates with Atypical Antipsychotic Agents. Journal of Pharmacy Technology. 18(1). 13–15.

Murphy, Tanya K., et al.. (2000). Selective serotonin reuptake inhibitors in the treatment of paediatric anxiety disorders: a review. International Clinical Psychopharmacology. 15. S47–S63. 28 indexed citations

Gören, Jessica L. & Gary M. Levin. (2000). Mania with Bupropion: A Dose-Related Phenomenon?. Annals of Pharmacotherapy. 34(5). 619–621. 14 indexed citations

Gören, Jessica L. & Gary M. Levin. (2000). Mania with Bupropion: A Dose-Related Phenomenon?. Annals of Pharmacotherapy. 34. 619–621. 4 indexed citations

Tan, Jennifer Y. & Gary M. Levin. (1999). Citalopram in the Treatment of Depression and Other Potential Uses in Psychiatry. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 19(6). 675–689. 37 indexed citations

10.

Gören, Jessica L. & Gary M. Levin. (1998). Quetiapine, an Atypical Antipsychotic. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 18(6). 1183–1194. 39 indexed citations

11.

Levin, Gary M., et al.. (1998). Effect of Over-the-Counter Dosages of Naproxen Sodium and Acetaminophen on Plasma Lithium Concentrations in Normal Volunteers. Journal of Clinical Psychopharmacology. 18(3). 237–240. 5 indexed citations

12.

Levin, Gary M., et al.. (1998). Compliance With Depot Antipsychotic Medication by Patients Attending Outpatient Clinics. Psychiatric Services. 49(9). 1232–1234. 48 indexed citations

13.

Levin, Gary M., et al.. (1996). Preclinical Exposure in a Baccalaureate Program in Pharmacy. American Journal of Pharmaceutical Education. 60(2). 179–182. 6 indexed citations

14.

Levin, Gary M., et al.. (1996). Use of Atypical Antipsychotics on an As-Needed Basis. Journal of Pharmacy Technology. 12(4). 145–148. 6 indexed citations

15.

Levin, Gary M.. (1995). Clinical Evaluation of Psychotropic Drugs: Principles and Guidelines. Annals of Pharmacotherapy. 29(10). 1054–1054. 65 indexed citations

16.

Levin, Gary M.. (1995). Attention-Deficit/Hyperactivity Disorder: The Pharmacist's Role. American Pharmacy. 35(11). 10–16. 3 indexed citations

17.

Levin, Gary M., et al.. (1993). Case Report: Development of Precocious Puberty in Two Children Treated with Clonidine for Aggressive Behavior. Journal of Child and Adolescent Psychopharmacology. 3(2). 127–131. 2 indexed citations

18.

Bussing, Regina & Gary M. Levin. (1993). Methamphetamine and Fluoxetine Treatment of a Child with Attention-Deficit Hyperactivity Disorder and Obsessive-Compulsive Disorder. Journal of Child and Adolescent Psychopharmacology. 3(1). 53–58. 14 indexed citations

19.

Kemph, John P., et al.. (1993). Treatment of Aggressive Children with Clonidine: Results of an Open Pilot Study. Journal of the American Academy of Child & Adolescent Psychiatry. 32(3). 577–581. 89 indexed citations

20.

Hartshorn, Edward A., Gary M. Levin, & C. Lindsay DeVane. (1992). A Review of Cyclic Antidepressant-Induced Blood Dyscrasias. Annals of Pharmacotherapy. 26(3). 378–383. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact